Mid-German Sepsis Cohort (MSC): a prospective observational study of sepsis survivorship.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
17 03 2021
Historique:
entrez: 19 3 2021
pubmed: 20 3 2021
medline: 20 5 2021
Statut: epublish

Résumé

The Mid-German Sepsis Cohort (MSC) aims to investigate mid-term and long-term functional disabilities in sepsis survivors from intensive care unit (ICU) discharge until 1 year after. Secondary, post-acute mortality and morbidity, health-related quality of life and healthcare utilisation will be investigated. The MSC comprises adult (aged ≥18 years) patients who were treated for (severe) sepsis or septic shock on ICU. The participants were recruited between 15 April 2016 and 30 November 2018 from five German centres. Three thousand two hundred and ten patients with sepsis were identified, of which 1968 survived their ICU stay and were eligible for enrolment in the follow-up cohort. Informed consent for follow-up assessment was provided by 907 patients (46.1% of eligible patients). The recruitment of the participants for follow-up assessments and the baseline data collection is completed. Incidence of sepsis was 116.7 patients per 1000 ICU patients. In this cohort profile, we provide an overview of the demographics and the clinical characteristics of both the overall sepsis cohort and the ICU survivors who provided informed consent for follow-up assessment (907 out of 1968 ICU survivors (46.1%)). The follow-ups are conducted 3, 6 and 12 months after ICU discharge. Another yearly follow-up up to 5 years after ICU discharge is pursued. Several cooperation and satellite projects were initiated. This prospective cohort offers a unique resource for research on long-term sequelae of sepsis survivors. German Clinical Trials Registry (DRKS00010050).

Identifiants

pubmed: 33737430
pii: bmjopen-2020-043352
doi: 10.1136/bmjopen-2020-043352
pmc: PMC7978081
doi:

Banques de données

DRKS
['DRKS00010050']

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e043352

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: CSH declares funding from the German Federal Joint Committee Innovations-Funds and the European Society of Intensive Care Medicine. All other authors declare no conflicts of interest.

Références

PLoS One. 2014 Dec 30;9(12):e116304
pubmed: 25549097
Intensive Care Med. 2007 Apr;33(4):606-18
pubmed: 17323051
N Engl J Med. 2013 Oct 3;369(14):1306-16
pubmed: 24088092
Am J Respir Crit Care Med. 2019 Oct 15;200(8):972-981
pubmed: 31161771
Nat Rev Neurol. 2009 Jul;5(7):372-9
pubmed: 19578344
Lancet Respir Med. 2014 May;2(5):380-6
pubmed: 24740011
BMJ Open. 2017 Aug 23;7(8):e016827
pubmed: 28838900
Lancet Infect Dis. 2017 Nov;17(11):1180-1189
pubmed: 28826588
JAMA. 2010 Oct 27;304(16):1787-94
pubmed: 20978258
J Infect Chemother. 2014 Mar;20(3):157-62
pubmed: 24530102
Anaesthesist. 2010 Apr;59(4):347-70
pubmed: 20414762
Am J Crit Care. 2019 Nov;28(6):424-432
pubmed: 31676516
Nat Rev Immunol. 2013 Dec;13(12):862-74
pubmed: 24232462
Intensive Care Med. 2016 Dec;42(12):1980-1989
pubmed: 27686355
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
BMJ Open. 2018 Apr 4;8(4):e019342
pubmed: 29622574
Crit Care Med. 2018 Sep;46(9):1393-1401
pubmed: 29787415
J Infect Dis. 2020 Jul 21;222(Suppl 2):S74-S83
pubmed: 32691830
Intensive Care Med. 2018 Nov;44(11):1826-1835
pubmed: 30284637
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Crit Care Med. 2013 Jan;41(1):69-75
pubmed: 23222259
Mol Neurobiol. 2019 Jan;56(1):186-251
pubmed: 29687346
BMJ Open. 2020 Jun 23;10(6):e036527
pubmed: 32580988
Crit Care. 2009;13(3):R103
pubmed: 19566927
Aust Crit Care. 2018 Jul;31(4):204-211
pubmed: 28736089
Lancet. 2020 Jan 18;395(10219):200-211
pubmed: 31954465
J Crit Care. 2019 Oct;53:149-154
pubmed: 31247513

Auteurs

Carolin Fleischmann-Struzek (C)

Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.

Miriam Kesselmeier (M)

Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Research Group Clinical Epidemiology, CSCC, Jena University Hospital, Jena, Germany.
Institute of Medical Statistics, Computer and Data Sciences, Jena University Hospital, Jena, Germany.

Dominique Ouart (D)

Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.

Christiane S Hartog (CS)

Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.
Department of Anesthesiology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Klinik Bavaria Kreischa, Kreischa, Germany.

Michael Bauer (M)

Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.

Sven Bercker (S)

Department of Anaesthesiology and Intensive Care Medicine, University Hospital Leipzig, Leipzig, Germany.

Michael Bucher (M)

Department of Anesthesiology and Critical Care Medicine, Halle-Wittenberg University, Halle, Germany.

Andreas Meier-Hellmann (A)

Helios-Kliniken, Berlin, Berlin, Germany.

Sirak Petros (S)

Medical Intensive Care Unit, University Hospital Leipzig, Leipzig, Germany.

Torsten Schreiber (T)

Zentrum für Anästhesie, Intensivmedizin und Notfallmedizin, Zentralklinik Bad Berka GmbH, Bad Berka, Germany.

Philipp Simon (P)

Department of Anaesthesiology and Intensive Care Medicine, University Hospital Leipzig, Leipzig, Germany.

Lorenz Weidhase (L)

Medical Intensive Care Unit, University Hospital Leipzig, Leipzig, Germany.

Sebastian Born (S)

Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.

Anke Braune (A)

Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Center for Clinical Studies, Jena University Hospital, Jena, Germany.

Hicham Chkirni (H)

Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Center for Clinical Studies, Jena University Hospital, Jena, Germany.

Cornelia Eichhorn (C)

Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Center for Clinical Studies, Jena University Hospital, Jena, Germany.

Sandra Fiedler (S)

Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Center for Clinical Studies, Jena University Hospital, Jena, Germany.

Christin Gampe (C)

Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Center for Clinical Studies, Jena University Hospital, Jena, Germany.

Christian König (C)

Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.

Stephanie Platzer (S)

Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Center for Clinical Studies, Jena University Hospital, Jena, Germany.

Heike Romeike (H)

Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.

Kristin Töpfer (K)

Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.

Konrad Reinhart (K)

Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Department of Anesthesiology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.

André Scherag (A)

Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany andre.scherag@med.uni-jena.de.
Research Group Clinical Epidemiology, CSCC, Jena University Hospital, Jena, Germany.
Institute of Medical Statistics, Computer and Data Sciences, Jena University Hospital, Jena, Germany.
Center for Clinical Studies, Jena University Hospital, Jena, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH